Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003411)

HILIC NEGATIVE ION MODE (Analysis AN005602)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15	F16
Coenzyme A 408	ME895423	2.54	2.41	1.84	2.48	2.50	2.36	2.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Arginine 131	ME895388	0.26	0.32	0.29	0.24	0.25	0.19	0.20	1.78	1.82	1.84	1.78	1.79	1.85	1.81	1.83	1.62
Butyryl-CoA 408	ME895431	2.82	3.03	2.25	2.39	2.31	2.31	2.15	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00
Acetyl-CoA 461	ME895428	2.32	2.24	2.10	2.40	2.41	2.35	2.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	NA
Asparagine 113	ME895375	0.47	0.52	0.66	0.48	0.52	0.51	0.42	1.68	1.68	1.68	1.68	1.66	1.72	1.64	1.78	0.34
Citric 111	ME895396	2.30	2.23	2.10	2.37	2.47	2.31	2.07	0.10	0.11	0.12	0.10	0.10	0.12	0.13	0.04	0.00
Glutamic acid 102	ME895382	1.16	1.30	1.20	1.23	1.15	1.20	1.18	1.08	1.10	1.10	1.08	1.08	1.11	1.06	1.02	0.44
Acetyl-CoA 79	ME895426	2.46	2.47	2.22	2.70	2.56	2.53	2.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fumaric 71	ME895369	2.36	2.56	2.25	2.41	2.24	2.28	2.30	0.13	0.12	0.11	0.13	0.13	0.12	0.12	0.05	0.02
Folic 311	ME895413	0.15	0.19	0.16	0.13	0.15	0.11	0.12	1.44	1.45	1.45	1.42	1.43	1.53	1.47	1.34	7.20
Butyryl-CoA 79	ME895430	2.78	2.96	2.21	2.43	2.23	2.35	2.21	0.01	0.02	0.02	0.02	0.01	0.02	0.03	0.02	0.01
Aspartic 88	ME895376	0.96	1.09	0.98	1.04	0.98	1.00	1.01	1.23	1.26	1.23	1.26	1.27	1.23	1.23	1.25	0.49
Glutamic acid 128	ME895383	1.15	1.34	1.18	1.25	1.14	1.19	1.16	1.07	1.16	1.08	1.10	1.09	1.15	1.05	1.00	0.32
C75 209	ME895403	1.83	0.64	0.03	0.44	0.90	0.10	0.00	4.76	2.33	0.15	2.06	3.37	0.71	0.00	0.00	0.00
Citric 173	ME895397	2.24	2.10	2.09	2.28	2.43	2.20	1.97	0.12	0.13	0.15	0.13	0.13	0.15	0.15	0.06	0.00
Glucose 59	ME895393	0.24	0.30	0.26	0.21	0.22	0.16	0.17	1.75	1.77	1.78	1.75	1.76	1.79	1.76	1.87	2.32
FAD 408	ME895425	2.53	2.45	1.83	2.41	2.10	2.18	2.29	0.03	0.02	0.02	0.03	0.03	0.03	0.02	0.03	NA
Glucose 71	ME895394	0.18	0.22	0.20	0.16	0.16	0.12	0.13	1.72	1.75	1.76	1.72	1.72	1.78	1.73	1.89	2.63
Coenzyme A 79	ME895422	2.69	2.49	1.99	2.58	2.49	2.52	2.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cystine 120	ME895401	0.01	0.01	0.01	0.01	0.01	0.00	0.01	2.07	2.08	2.06	2.04	2.07	2.11	2.06	2.25	0.78
Butyric PAR	ME895365	1.20	0.08	1.08	0.62	1.17	1.05	1.07	0.20	2.34	1.70	0.82	1.08	2.34	0.95	0.23	1.47
Formic PARENT	ME895360	0.57	0.21	0.25	0.30	0.56	0.24	0.48	1.10	0.87	2.79	2.72	1.27	1.38	1.51	1.65	1.82
Acetic PAR	ME895361	0.34	1.60	2.62	0.14	4.65	1.96	0.22	0.17	0.16	0.04	0.60	0.28	0.04	0.16	0.09	1.38
FAD 79	ME895424	2.64	2.73	2.04	2.58	2.35	2.31	2.47	0.02	0.03	0.03	0.03	0.02	0.03	0.03	0.03	0.00
Ascorbic acid 157	ME895391	1.80	1.64	1.44	1.59	1.54	1.47	1.48	0.36	0.40	0.40	0.48	0.40	0.44	0.40	0.31	1.43
Arginine 156	ME895389	0.20	0.24	0.22	0.18	0.19	0.14	0.15	1.82	1.88	1.90	1.83	1.82	1.93	1.86	1.90	1.58
Alanine NEG PAR	ME895364	1.68	1.71	1.51	1.60	1.53	1.59	1.42	0.75	0.82	0.83	0.80	0.80	0.86	0.79	0.21	0.66
Aspartic 115	ME895377	0.89	1.03	0.91	0.97	0.93	0.93	0.94	1.30	1.31	1.30	1.28	1.30	1.32	1.29	1.35	0.43
Cystine 74	ME895402	0.01	0.01	0.01	0.01	0.01	0.00	0.01	2.07	2.08	2.14	2.02	2.03	2.13	2.05	2.30	0.68
Ascorbic acid 79	ME895392	NA	0.97	1.27	0.93	NA	0.46	0.59	0.76	0.66	0.63	0.64	0.59	0.72	0.49	0.41	1.05
Acetyl-CoA 408	ME895427	2.40	2.30	2.13	2.46	2.45	2.37	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Citrulline 131	ME895390	0.50	0.46	0.46	0.43	0.41	0.36	0.37	1.79	1.72	1.78	1.74	1.68	1.82	1.73	1.84	0.33
aCD 161	ME895441	1.32	1.40	0.71	1.48	0.78	0.85	0.68	0.88	0.93	1.32	1.17	1.24	0.85	0.61	0.73	0.99
Cysteine PARENT	ME895372	1.92	2.18	1.68	2.16	1.99	1.95	1.74	0.28	0.31	0.19	0.36	0.24	0.18	0.33	0.23	2.31

Factors:

F1	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug Treatment:100 uM C75
F2	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug Treatment:15 uM C75
F3	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug Treatment:1 uM C75
F4	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug Treatment:20 uM C75
F5	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug Treatment:40 uM C75
F6	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug Treatment:5 uM C75
F7	Sample source:BT-474 Breast cancer cells \| Sample Type:Intracellular \| Drug Treatment:Control
F8	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug Treatment:100 uM C75
F9	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug Treatment:15 uM C75
F10	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug Treatment:1 uM C75
F11	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug Treatment:20 uM C75
F12	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug Treatment:40 uM C75
F13	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug Treatment:5 uM C75
F14	Sample source:BT-474 Breast cancer cells \| Sample Type:Medium \| Drug Treatment:Control
F15	Sample source:NA \| Sample Type:Medium \| Drug Treatment:NA
F16	Sample source:NA \| Sample Type:QC \| Drug Treatment:NA

Data matrix